Moreover, Tau downregulates BDNF in Alzheimer’s disease mouse models [401], while Alzheimer’s patients carrying the BDNF val66met polymorphism show increased Tau levels and Tau phosphorylation [402]. Here, MAPT is linked to Alzheimer disease.